Evolent Health, Inc.
EVH
$2.99
-$0.07-2.29%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,781.99% | 9.82% | -1,346.68% | -273.95% | 31.75% |
| Total Depreciation and Amortization | 2,717.84% | -23.02% | -24.29% | -23.47% | -93.93% |
| Total Amortization of Deferred Charges | 17.17% | 31.52% | -6.46% | 3.62% | -19.62% |
| Total Other Non-Cash Items | 1,123.56% | 12.05% | 67.02% | 127.29% | 7.89% |
| Change in Net Operating Assets | 180.53% | -64.10% | -128.54% | 39.90% | -175.93% |
| Cash from Operations | 286.04% | -15.31% | -241.64% | -7.01% | -129.35% |
| Capital Expenditure | 1,778.02% | 48.18% | -416.96% | -94.49% | 142.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -194.58% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 108.11% | 88.68% | -- | -- |
| Cash from Investing | 512.21% | 55.59% | -347.02% | -34.54% | -229.31% |
| Total Debt Issued | -68.75% | -- | -- | -- | -85.04% |
| Total Debt Repaid | -21,598.87% | -- | -- | -11,714.74% | 100.13% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 81.29% | -5,758.82% | 92.31% | 67.96% | 67.16% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 62.43% | 8.80% | 9.87% | 6.90% |
| Other Financing Activities | -94.31% | 75.96% | 95.64% | -222.84% | 176.28% |
| Cash from Financing | -195.97% | -364.20% | 91.36% | 624.73% | 214.93% |
| Foreign Exchange rate Adjustments | -65.44% | -548.39% | -245.83% | 160.53% | -655.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.58% | -246.27% | -4.55% | 891.41% | 4,965.03% |